User:Mssciguy/sandbox/Afrezza

This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft.

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL
Easy tools: Citation bot (help) | Advanced: Fix bare URLs
This page was last edited by Cydebot (talk | contribs) 5 years ago. (Update timer)

Finished writing a draft article? Are you ready to request an experienced editor review it for possible inclusion in Wikipedia? Submit your draft for review!

Afrezza is a drug-device combination product that consists of a dry formulation of human insulin delivered from a small and portable inhaler to help patients achieve blood sugar control. Afrezza is rapidly absorbed and has a short duration of action. It is administered at the beginning of a meal. Afrezza can help control high blood sugar as part of a diabetes management plan that may include diet, exercise and other diabetes medications.

Afrezza should not be used in patients with chronic lung disease such as asthma or COPD. Afrezza cannot be used to treat diabetic ketoacidosis. Afrezza is not recommended in patients who smoke or who have recently stopped smoking. ^[1] new article content ...

References

^ . Sanofi http://en.sanofi.com/Images/38264_20150203_Afrezza_en.pdf. {{cite web}}: Missing or empty |title= (help)

External links

www.example.com

[1] . Sanofi http://en.sanofi.com/Images/38264_20150203_Afrezza_en.pdf. {{cite web}}: Missing or empty |title= (help)

[1]